Corroding dental implants can shed titanium particles that jam the immune system and erode the jawbone

Titanium dental implants can shed microscopic particles as bacteria corrode them, and a Rutgers School of Dental Medicine team reports that those particles push the immune cells meant to clear infection into a stuck, inflamed state. The work, published in PNAS Nexus, offers an explanation for why peri-implantitis, the inflammation around an implant that gradually destroys the supporting jawbone, so often resists antibiotics.

Stay ahead on AI: Join 600,000+ professionals who read The Deep View, the daily newsletter that keeps you up to date with artificial intelligence.

Subscribe to The Deep View →

We may earn a commission if you sign up.

An estimated 10% to 20% of implant patients develop peri-implantitis, according to the university’s summary of the problem. The new paper does not measure that rate. It asks what keeps the inflammation going once it starts, and it points to the metal itself as a contributor rather than bacteria alone. In the university’s account, standard care for infection around teeth, which relies heavily on antibiotics, has not carried over to implants, and that mismatch is what the authors set out to explain. Their answer is that the problem is not only a bacterial infection but also an interaction between microbes, corroded metal and the host’s own defenses.

How titanium particles reach the immune system

The paper, Implant-derived titanium particles impair macrophage bacterial clearance via TRPC1 and lysosomal dysfunction, appeared online on March 21, 2026, in the April issue of PNAS Nexus. Georgios Kotsakis is the senior author, and the other authors are Juliana Giron Bastidas, Danyal Siddiqui, Viviane Nascimento Da Conceicao, Yuyang Sun, Mashael Al Thunayan and Brij Singh. They propose that bacteria living on the implant surface form acidic biofilms that corrode titanium and release particles, which then bind a bacterial toxin called lipopolysaccharide.

Coated in that toxin, the particles resemble bacteria that macrophages cannot digest. In laboratory tests, macrophages exposed to the particles engulfed fewer than half as many bacteria as unexposed cells, and they stayed locked in prolonged inflammation, releasing large amounts of the signaling molecule interleukin-1 beta. In one set of experiments reported in the paper, uptake of fluorescently labeled oral bacteria fell from about 14% of cells in controls to about 2.6% with particles alone.

Other experiments in the paper, which is indexed under DOI 10.1093/pnasnexus/pgag081, describe what the particles do inside the cells. They reduced actin polymerization, the cellular scaffolding macrophages use to move and engulf targets, after 24 hours, and they impaired the acidification of lysosomes while increasing release of cathepsin B, an enzyme that leaks out when lysosomal membranes become permeable. TRPC1-deficient cells and mice produced less interleukin-1 beta, interleukin-6 and tumor necrosis factor alpha, three of the signals that sustain inflammation around an implant.

TRPC1 and the evidence from mice

The mechanism centers on TRPC1, a calcium channel in macrophages. According to the paper, the particles overactivate calcium entry through that channel, which impairs the lysosomes that digest engulfed material and blunts the cells’ ability to clear bacteria. Mice genetically engineered to lack TRPC1 made fewer inflammatory molecules, cleared bacteria better and developed much smaller abscesses than normal mice, assessed at seven days after exposure to titanium particles and bacteria. The researchers say disabling the channel prevented the disease process.

The human evidence is thinner. In the paper, cells scraped from the tissue around diseased implants were examined at five sites, and four of the five showed particles inside cells; the paper also reports higher TRPC1 in human peri-implantitis tissue than in healthy tissue. The sources read for this article do not give the number of mice or the size of the human tissue comparison, and much of the cell work used a laboratory macrophage line rather than cells taken directly from patients.

What the authors and the university say comes next

Kotsakis framed the finding as an explanation for a long-standing clinical frustration. In the Rutgers release of May 28, he said the study shows for the first time why the antibiotic treatments that work around natural teeth do not work around implants, and that knowing the cause lets researchers begin developing therapeutics. He described the situation in the ScienceDaily version as a perfect storm that defies antibiotics, in the sense that bacteria, corroded metal and a disabled immune response reinforce one another.

Those statements are the authors’ interpretation, and the work stops well short of a treatment. The university says drug candidates acting on the same pathway are being evaluated in human cells, with support from the National Institutes of Health, but no therapy has been tested in patients. A trade report in Dental Tribune notes the wording of the findings is tentative, with the mechanism described as something the particles may do, and that the only expert quoted is a study author rather than an independent clinician.

For now the practical result is a hypothesis with a named molecular target. The researchers believe they have identified the mechanism behind the failure of antibiotics around implants, and TRPC1 is a candidate to aim at, but whether the same chain of events dominates in patients is the question the next studies would have to answer. The release also characterizes TRPC1 as the first credible drug target for the condition, which is the university’s own description rather than an independent assessment, and the paper itself is a mechanistic study, not a clinical trial of implant patients.

This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.

Stay ahead on AI: Subscribe to The Deep View →

We may earn a commission if you sign up.